NRx Pharmaceuticals Future Growth
How is NRx Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
10.7%
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | N/A | N/A | N/A | -22 | 2 |
| 9/30/2022 | N/A | -316 | -43 | -43 | N/A |
| 6/30/2022 | N/A | -88 | -48 | -48 | N/A |
| 3/31/2022 | N/A | -337 | -45 | -45 | N/A |
| 12/31/2021 | N/A | -349 | -38 | -38 | N/A |
| 9/30/2021 | N/A | -108 | -27 | -27 | N/A |
| 6/30/2021 | N/A | -76 | -16 | -16 | N/A |
| 3/31/2021 | N/A | -76 | -4 | -4 | N/A |
| 12/31/2020 | N/A | -52 | -2 | -2 | N/A |
| 9/30/2020 | N/A | -8 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NRXP's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if NRXP's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if NRXP's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NRXP's revenue is forecast to grow faster than the US market.
High Growth Revenue: NRXP is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NRXP's Return on Equity is forecast to be high in 3 years time